RxDoctor Payments Data

Rupal Trivedi

Family Medicine · Saint Louis, MONPI 1265635502

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $527 of the $629 with a category attached, or 83.7%. 7 manufacturers reported payments, led by Modernatx, Inc. at 53.7% of the total. Reporting peaked in 2024 at $468 and has fallen 86.2% since, to $65 in 2025.

$629in general payments, 2019–2025

Across 16 payments — averaging $39.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$338
  • Medtronic$89
  • Novo Nordisk$85
  • Sanofi-aventis U.S. LLC$45
  • Philips North America LLC$32
  • Lilly USA, LLC$23
  • plus $18 from 1 others
$10,655,702in research payments, 2019–2025

Across 3,111 payments — averaging $3425.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biontech SE$3.3M
  • Modernatx, Inc.$2.8M
  • Amgen$1.3M
  • Eli Lilly$1.2M
  • Valneva Austria GmbH$1M
  • GSK$433K
  • plus $588K from 10 others

What the payments were for

  • Travel & lodging$386%
  • Food & beverage$52784%
  • Education$6510%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$629 in reported general payments places this provider in the 55th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Other family medicine in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →